Phase 2 Readout~quarter
Phase 2 Readout: opgx-lca5
- Company
- Opus Genetics, Inc. (IRD)
- Drug
- opgx-lca5
- Indication
- LCA5
Other upcoming events for IRD
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.